
1K
Downloads
57
Episodes
Zero Fluff. Pure Insight.
Get the latest scientific research without the small talk. We dive deep into new publications to give you clear, information-packed summaries—no filler, no chatter.
Stay tuned. Stay informed.
Zero Fluff. Pure Insight.
Get the latest scientific research without the small talk. We dive deep into new publications to give you clear, information-packed summaries—no filler, no chatter.
Stay tuned. Stay informed.
Episodes
6 hours ago
6 hours ago
8 min
E57 | 9 min | Latest | Publication Link
- Podcast based on: Konieczny, H.; Kruk, A.; Salagierski, M. Active Surveillance in Low- and Intermediate-Risk Prostate Cancer: Comparative Oncologic Safety, Patient Selection, and Predictors of Treatment Conversion in the Era of Multiparametric MRI: A Systematic Review and Meta-Analysis. Cancers 2026, 18, 3378. https://doi.org/10.3390/cancers18203378
Type: Systematic Review | Publication date: 19 October 2026 - Summary: Prostate cancer that is diagnosed at an early stage and deemed low-risk is increasingly managed through active surveillance. Prioritizing close clinical monitoring over immediate surgical intervention or radiotherapy protects patients from substantial treatment-related toxicities without compromising long-term survival. In this systematic review and meta-analysis, we synthesized evidence from 29 prospective studies and randomized trials comprising 46,318 men. Patients managed on active surveillance exhibited long-term cancer-specific survival comparable to those undergoing immediate radical treatment, while demonstrating substantially superior preservation of urinary, sexual, and bowel function. Sequential multiparametric MRI provided high negative predictive reliability for ruling out high-grade upgrading, supporting selective biopsy deferral under strict protocolized conditions. However, the presence of invasive cribriform histology was strongly associated with disease reclassification, indicating that such patients warrant close surveillance or timely curative intervention. These synthesized findings consolidate active surveillance as a safe standard of care for low-risk disease while establishing risk-adapted boundaries for monitoring intermediate-risk prostate cancer.
- Keywords: active surveillance; prostate cancer; multiparametric magnetic resonance imaging; PRECISE; cribriform pattern; meta-analysis; patient-reported outcomes
License and disclaimer:
Original article © 2026 by the authors. Licensed under the Creative Commons Attribution 4.0 (CC BY 4.0) license (https://creativecommons.org/licenses/by/4.0/). This episode is an AI-generated audio adaptation of the article: the script and the voices are synthetic, changes were made, and the adaptation is not endorsed by the authors, the journal, or the publisher. It may contain errors or omissions, so consult the original publication before relying on any detail. It is for educational purposes only and is not medical advice. The creators accept no liability for any use of this content.
6 hours ago
8 min

No comments yet. Be the first to say something!